The real question behind Mithril: can one person plus AI run an entire drug pipeline?
FinanceYF5 · x · 2026-10-29
If AI lets researchers advance multiple projects at once and spend more time on scientific judgment, it could mean better decisions, higher success rates, and more drugs. What Anthropic's acquisition really tests is a new model: can one person plus a stack of AI run an entire drug-discovery pipeline? As Professor Oak put it: Gotta Cure 'Em All.
Related event: Anthropic's Mithril acquisition sparks debate on AI drug discovery(2 posts)→
More from Companies & People
- 'Pipeline-in-a-Person': one person orchestrating AI and experts across multiple drug pipelines — FinanceYF5 · 2026-10-29
- 20VC: Anthropic files S-1 for $2T IPO, Microsoft lays off 27,000, Meta raises $95B — 20VC · 2026-10-29
- Microsoft's 4,800-person layoffs save what its AI data center spend burns in two days — aakashgupta · 2026-10-29
- Dev questions Anthropic ops: Claude Code source leaked to prod, backbone outages 'routine' — cuenca · 2026-10-29
- Thiel Fellowship's wild ROI: 40 under-20 fellows founded 13 unicorns, 4 are billionaires — FinanceYF5 · 2026-10-29
- KUKA CEO on physical AI: how 600,000 deployed robots learn new tricks — lukas_m_ziegler · 2026-10-29